Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beasley

Showing results (461-470 of 482) with videos related to

Pageof 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanomaGeorge Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter AnalysisJohn T Miura, Hidde M Kroon, Georgia M Beasley, et al.
Annals of Surgical Oncology|May 4, 2024
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
JAMA Surgery|October 22, 2025
Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 StudyTina J Hieken, Michael E Egger, Christina V Angeles, et al.
Annals of Surgical Oncology|July 18, 2024
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|December 11, 2024
ASO Visual Abstract: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)James W Jakub, Michael Lowe, J Harrison Howard, et al.
Pageof 49

Showing results (461-470 of 482) with videos related to

Sort By:
Pageof 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanomaGeorge Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter AnalysisJohn T Miura, Hidde M Kroon, Georgia M Beasley, et al.
Annals of Surgical Oncology|May 4, 2024
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
JAMA Surgery|October 22, 2025
Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 StudyTina J Hieken, Michael E Egger, Christina V Angeles, et al.
Annals of Surgical Oncology|July 18, 2024
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|December 11, 2024
ASO Visual Abstract: Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-Institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)James W Jakub, Michael Lowe, J Harrison Howard, et al.
Pageof 49